Brief: Immunicum: Positive Review By Data Safety Monitoring Board For Phase Ib Part Of ILIAD Study
26/07/2021 07:04
July 26 (Reuters) - Immunicum AB IMMUN.ST :
* REG-IMMUNICUM ANNOUNCES POSITIVE REVIEW BY DATA SAFETY
MONITORING BOARD FOR PHASE IB PART OF ILIAD STUDY
* EXPECTS RESULTS FROM PHASE IB PART LATER THIS YEAR
* WILL PROVIDE FURTHER GUIDANCE ON CLINICAL DEVELOPMENT
PLANNING
BEFORE END OF 2021
Source text for Eikon: ID:nGNEb7s00z
Further company coverage: IMMUN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))